Position in ALEC
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$610,206
+$299,571 QoQ
Shares Held
283,817
+42.5% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 62%
Shared 9%
None 29%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ALEC ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ALEC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $610,206 | 283,817 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $310,635 | 199,126 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $875,703 | 295,846 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $536,662 | 383,331 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $601,879 | 489,334 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,667,205 | 882,120 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,377,980 | 724,889 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,069,383 | 676,076 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,092,702 | 845,964 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $6,099,862 | 764,394 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $4,414,336 | 681,225 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,322,471 | 552,824 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,720,763 | 439,542 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,523,216 | 165,029 | Shares | Sole | 2023-02-09 | |
| 2022-06-30 | $450,462 | 44,337 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,501,739 | 386,087 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,302,038 | 159,905 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,735,917 | 76,070 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,584,538 | 76,070 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $5,499,931 | 273,085 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,323,103 | 87,449 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $929,956 | 88,273 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,701,830 | 69,633 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||